Researchers warn that the public, policy makers and even clinicians are not aware of the growing problem of liver cancer.

At least 60% of liver cancers globally are preventable through risk-factor reduction, including obesity-linked metabolic ...

Fatty liver disease is one of the fastest-growing health concerns worldwide, impacting roughly 32% of people worldwide, according to a 2022 systematic review. It is closely tied to rising rates of ...

Sixty percent of liver cancers are preventable by controlling risk factors including hepatitis B and C, alcohol consumption, ...

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD ...

MASLD is highly prevalent among individuals with chronic hepatitis B and increases the risk for liver fibrosis.

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent liver condition to date, with an estimated global prevalence of 38%.1 The progressive and inflammatory stages of ...

Higher cumulative exposure to uric acid is independently and dose-dependently associated with an increased risk for MASLD. Cumulative uric acid (UA) exposure is an independent risk factor for ...

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD (metabolic dysfunction-associated steatotic liver disease – previously called ...

Poor dietary habits and obesity are key contributors to non-alcoholic fatty liver disease (NAFLD).leading to inflammation and ...

In fact, heart disease is the most common cause of death among people who have metabolic dysfunction-associated steatotic liver disease (MASLD) (previously known as non-alcoholic liver disease).

MASLD stands for metabolic dysfunction-associated steatotic liver disease, and it’s a liver condition related to metabolic health. Taking steps like following a balanced diet, staying physically ...